Vanderbilt Vaccine Center

November 1, 2012

Genomic research gains ad-“vantage” with new resources

Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.

By Bill Snyder
July 19, 2012

Long antibodies better against HIV

Understanding how antibodies with long “loops” form may be important for HIV vaccine development.

By Leigh MacMillan
April 27, 2012

Dengue antibodies give vaccine leads

New information may help speed development of a vaccine or treatment for dengue fever.

By VUMC News and Communications
April 12, 2012

Targeting post-transplant diabetes

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.

By VUMC News and Communications
February 15, 2012

On the tail of RSV infection mechanism

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

By VUMC News and Communications
Richard Powell
January 20, 2012

Digestive disease research bolstered by grant renewal

The Vanderbilt Digestive Disease Research Center celebrates its 10th anniversary this year with a second five-year renewal of its federal research grant.

By Bill Snyder
October 7, 2011

Diversity key in antibody repertoire

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.
By VUMC News and Communications
January 6, 2011

Aliquots – VUMC research highlights

By VUMC News and Communications
June 17, 2008

$2.4 million NIH grant puts Children’s Hospital researcher at forefront of new direction in HIV research

After recent efforts to develop a vaccine to protect against AIDS proved ineffective, the National Institutes of Health announced a change in research direction; and it\'s one that will involve the lab of James Crowe, M.D., professor of Pediatrics, Microbiology and Immunology at the Monroe Carell Jr. Children\'s Hospital at Vanderbilt.
By VUMC News and Communications
May 25, 2007

Senior Day Study Break Video: "Influenza: A Concern for All People (pan demos)"

James Crowe, M.D., is a Vanderbilt professor of pediatrics, microbiology and immunology. Crowe discussed the concerns associated with possible influenza pandemic.
September 25, 2006

Vanderbilt Children’s Hospital Ranks Sixth in Nation for NIH Research Funding

Moving up two places from rankings announced last year, researchers from the Department of Pediatrics at the Monroe Carell Jr. Children's Hospital at Vanderbilt are listed as sixth in the nation for federal funding of pediatric research with grants in 2005 totaling $20,238,000.
By VUMC News and Communications
May 27, 2003

Vanderbilt, Meharry establish new Center for AIDS Research

Vanderbilt and Meharry have been collaborating with NIH for several years on research involving HIV/AIDS, which is spread primarily by sexual contact and intravenous drug use. The goal of the new grant is to encourage further collaboration between the schools, and train new investigators to advance AIDS treatment and prevention.
By Bill Snyder
1 … 11 12 13 14